IRIS
VALENTINI, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.791
NA - Nord America 5.292
AS - Asia 932
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 3
OC - Oceania 2
Totale 18.050
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.095
US - Stati Uniti d'America 5.218
IE - Irlanda 1.842
UA - Ucraina 1.115
GB - Regno Unito 773
FR - Francia 537
DE - Germania 506
CN - Cina 365
FI - Finlandia 280
SG - Singapore 278
SE - Svezia 250
GR - Grecia 192
TR - Turchia 190
CA - Canada 73
BE - Belgio 68
KR - Corea 39
IN - India 26
ES - Italia 21
PL - Polonia 20
CH - Svizzera 18
NL - Olanda 14
EU - Europa 12
BR - Brasile 11
RO - Romania 9
RU - Federazione Russa 9
AT - Austria 8
CZ - Repubblica Ceca 8
TW - Taiwan 8
HR - Croazia 7
ID - Indonesia 7
HU - Ungheria 5
JP - Giappone 5
BY - Bielorussia 3
EC - Ecuador 3
AP - ???statistics.table.value.countryCode.AP??? 2
AU - Australia 2
DK - Danimarca 2
EG - Egitto 2
HK - Hong Kong 2
IQ - Iraq 2
IR - Iran 2
MK - Macedonia 2
NO - Norvegia 2
BD - Bangladesh 1
BG - Bulgaria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SM - San Marino 1
TH - Thailandia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 18.050
Salva come PNG Salva come JPEG
Città #
Dublin 1.836
Jacksonville 1.574
Chandler 756
Rome 346
Princeton 287
Milan 280
Medford 254
Singapore 175
Ann Arbor 166
Napoli 156
San Mateo 152
Boardman 147
Roxbury 147
Beijing 143
Wilmington 137
Woodbridge 113
Bremen 112
Naples 106
Cambridge 81
Florence 73
Palermo 70
Turin 67
Des Moines 64
Mountain View 64
Brussels 62
Caserta 54
Ottawa 51
Nanjing 48
Catania 46
Padova 46
Bari 41
Ashburn 40
New York 38
Bologna 37
Seoul 35
Torino 27
Verona 27
Helsinki 25
Mcallen 23
Pescara 23
Genoa 21
Houston 21
Redwood City 21
Jinan 19
Messina 19
Cagliari 18
Dallas 18
Genova 18
Brescia 17
Düsseldorf 17
Kunming 17
Norwalk 17
Vicenza 17
Gorno 15
Parma 15
Venice 15
Auburn Hills 14
Salerno 14
Taranto 14
Trieste 14
Falls Church 13
Hebei 13
Montréal 12
Munich 12
Perugia 12
Reggio Calabria 12
Belluno 11
Livorno 11
Nanchang 11
Ningbo 11
Terni 11
Torre del Greco 11
Trento 11
Varese 11
Bergamo 10
Fiano Romano 10
Guangzhou 10
Lanzhou 10
Mykolayiv 10
Reggio Emilia 10
Bastia umbra 9
Cosenza 9
Hanover 9
Lecce 9
Lucca 9
Marano Di Napoli 9
Rimini 9
Assisi 8
Brno 8
Carbonera 8
Hefei 8
Latina 8
Los Angeles 8
Monza 8
Paris 8
Pavia 8
Prato 8
Sacramento 8
Sassari 8
Seattle 8
Totale 8.659
Salva come PNG Salva come JPEG
Nome #
ARTRITE PSORIASICA ED INTERSTIZIOPATIA POLMONARE : DESCRIZIONE DI UN CASO CLINICO. 6.164
ANTI TNF ALFA IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE E SPONDILOARTRITI HBV CARRIERS OCCULTI:STUDIO RETROSPETTIVO SULLA SICUREZZA 198
A PILOT STUDY ON LOW-DOSE INTRAVENOUS CICLOPHOSPHAMIDE IN SYSTEMIC SCLEROSIS: EFFICACY, SAFETY AND EFFECTS ON CELLULAR ACTIVATION MARKERS 101
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 90
ANTI-TNFα TREATMENT IS ASSOCIATED WITH INCREASED LIVER STIFFNESS IN HBV OCCULT CARRIER PATIENTS 86
Early Systemic Sclerosis: Marker Autoantibody Positive Patients Have A Faster Pace Of The Disease. 80
Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency 79
Antinuclear antibodies in first-degree relatives of patients with polymyositis-dermatomyositis: analysis of the relationship with HLA haplotypes 79
Clinical and subclinical atherosclerosis in systemic sclerosis: consequences of previous corticosteroid treatment. 76
Early systemic sclerosis: Analysis of the disease course in patients with marker autoantibody or capillaroscopic positivity or both. 75
Clinical correlates of human leukocyte antigen-G (HLA-G) in systemic sclerosis. 74
[HAQ-DI Italian version in systemic sclerosis]. 74
Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation 73
EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research 66
-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis 66
CXCL4 in undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (previously referred to as very early SSc) 64
[T-lymphocyte subpopulations in the conjunctiva of subjects with secondary Sjogren's syndrome] 63
.ANTI-TNF alfa IN PATIENTS WITH EITHER RHEUMATOID ARTHRITIS OR SPONYLOATHRITIS And CONCURRENT C HEPATITIS:A RETROSPECTIVE RECORD REVIEW ON SAFETY 63
Alterazioni del sistema nervoso autonomo nella Sclerosi Sistemica (SSc). Risultati preliminari di uno studio sul rapporto con la severita della malattia 62
Sub-Analysis of ELF Score Biomarkers Components Indicates a Specific Correlation with Different Organ Involvement in Systemic Sclerosis. 61
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 61
Evaluation of cardiac structures and function in systemic sclerosis by Doppler echocardiography 60
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population 60
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 60
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 60
Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases. 59
Tissue Doppler imaging in systemic sclerosis: A 3-year longitudinal study. 59
Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers. 59
[Comparison between auranofin and chloroquine in the therapy of rheumatoid arthritis] 59
Cardiac involvement in rheumatoid arthritis: an echocardiographic study 58
Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis 57
ARTHRITIS IS ASSOCIATED WITH PSORIASIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 57
ELF Score: A Validated Serum Test Strongly Predictive of Fibrosis in Systemic Sclerosis. 57
RELATIONSHIP OF THE 6-MIN WALKING TEST AND QUALITY OF LIFE 57
Low-dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease 56
Systemic sclerosis could mask the presentation of psoriasis in a patient with symptomatic and bilateral sacroiliitis 56
Crioglobulinemia mista essenziale: prevalenza e caratteri della neuropatia periferica 56
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database 55
Effects and safety of rituximab in systemic sclerosis: An analysis from the European Scleroderma Trial and Research (EUSTAR) group 55
Glucocorticoids in systemic sclerosis: weighing the benefits and risks - a systematic review 55
Alterazione del riempimento ventricolare sinistro nella sclerosi sistemica (SSc): risultati di uno studio Iongitudinale 55
Succesfull neridronate therapy in transient osteoporosis of the hip 55
Morphea developing in patients previously affected with eosinophilic fasciitis. Report of two cases 55
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus 55
High IL-17E and Low IL-17C Dermal Expression Identifies a Fibrosis-Specific Motif Common to Morphea and Systemic Sclerosis. 54
Impaired exercise performance in systemic sclerosis and its clinical correlations 54
Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features 54
ATHEROSCLEROSIS AND RHEUMATOID ARTHRITIS: EVALUATION OF INTIMA-MEDIA THICKNESS AND CORRELATION WITH INFLAMMATORY AND ATHEROGENIC MARKERS 54
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 54
Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries 53
Cell-free DNA in the plasma of patients with systemic sclerosis 53
[Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the "3E initiative"]. 53
[A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens]. 53
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients 53
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis 53
Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): Efficacy of maintenance immunosuppression in responders and non-responders. 53
[Survival and death causes in 251 systemic sclerosis patients from a single Italian center]. 53
ANTI-TOPOISOMERASE I (ANTI-SCL-70) AND CANCER IN SYSTEMIC SCLEROSIS. ARE THEY RELATED? 53
Glucocorticoids in systemic sclerosis: patients' beliefs and treatment adherence. 52
PREVALENCE OF ANTIBODIES RECOGNAIZING CYCLIC CITRULLINATED PEPTIDE(anti CCP) IN PATIENTS WITH ULCERATIVE COLITIS 52
Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin 52
Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve 52
Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients 52
Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions 52
Right atrial morphology and function in patients with systemic sclerosis compared to healthy controls: a two-dimensional strain study 52
VALIDATION OF THE SIMPLIFIED DISEASE ACTIVITY INDEX (SDAI) AND DAS28 AS MEASURE OF RESPONSE TO TREATMENT IN PATIENTS UNDERGOING DIFFERENT THERAPEUTIC REGIMENS 52
New strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: A systematic analysis. 51
RELAPSING POLYCHONDRITIS. AN HYSTOCHEMICAL STUDY BY LECTIN. 51
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative 51
Evidence for peripheral impaired glucose handling in patients with connective tissue diseases 51
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 51
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) 51
Early Systemic Sclerosis: Serum Profiling of Factors Involved in Endothelial, T-cell, and Fibroblast Interplay is Marked by Elevated Interleukin-33 Levels. 51
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study 51
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group 50
[Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs]. 50
Factors influencing pain, physical function and social functioning in patients with osteoarthritis in southern Italy. 50
Twelve-month azathioprine as maintenance therapy in early diffuse systemic sclerosis patients treated for 1-year with low dose cyclophosphamide pulse therapy 50
Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease. 50
Thrombocytosis in progressive generalized sclerosis (scleroderma) and in other rheumatic diseases 50
[Absolute and relative increase in Leu-11b+ cells in patients with systemic scleroderma] 50
Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: A long-term retrospective cohort study 50
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study 50
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis. 50
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis 49
The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy 49
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study 49
Anti-inflammatory: new trends in the treatment of the patient with systemic sclerosis 49
European Scleroderma Study Group (ESCSG) Activity Index is correlated to quality of life measures both at admission and overtime 49
Brief report: Successful pregnancies but a higher risk of preterm births in systemic sclerosis: An Italian multicentric study. 49
Aggressive rheumatoid arthritis registry in Italy. Characteristics of the early rheumatoid arthritis subtype among patients classified according to the ACR criteria 49
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: Derivation and validation of a preliminarily revised EUSTAR activity index 49
Scleroderma renal crisis analysis of prevalence and outcome in a large italian series. 48
The use of monoclonal antibody against alpha-1 antitripsin in diagnostic screening of inflammatory disorders 48
Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data 48
The assessment of the patient with systemic sclerosis. Introduction 48
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population 47
Studio neurofisiologico in 17 casi di crioglobulinemia. Rivista Italiana di EEG e Neurofisiologia Clinica : , 47
Development of a provisional core set of response measures for clinical trials of systemic sclerosis 47
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres 47
Totale 11.913
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.975
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.099 0 341 119 61 303 102 422 181 251 127 106 86
2020/20213.084 282 76 331 164 466 111 381 316 137 362 311 147
2021/20222.629 245 77 93 103 736 103 106 161 134 120 201 550
2022/20234.521 429 195 113 303 393 316 112 297 1.763 184 204 212
2023/20242.784 195 131 182 285 626 109 189 230 130 161 228 318
2024/2025259 125 134 0 0 0 0 0 0 0 0 0 0
Totale 18.636